Skip to main content

Table 4 Left ventricular outcomes versus PDM/DM: Adjusted Model #2 (Reference = No PDM/DM)

From: Glycemic status, non-traditional risk and left ventricular structure and function in the Jackson Heart Study

Left Ventricular Measures

Prediabetes

Sig

Diabetes

Sig

n

Mean difference

Percent parameter difference (95% CI)

Mean difference

Percent parameter difference (95% CI)

Left Ventricular Ejection Fraction (%)

0.40

0.65 (− 0.58, 1.91)

0.302

− 0.14

− 0.233 (− 2.15, 1.72)

0.814

2082

Left Ventricular Fractional Shortening (%)

− 0.68

− 1.75 (− 3.73, 0.28)

0.090

− 0.16

− 0.42 (− 3.60, 2.86)

0.798

1512

Left Ventricular End Diastolic Volume (ml/m2)

− 1.15

− 2.82 (− 4.66, − 0.95)

0.003

− 0.66

− 1.23 (− 4.15, 1.77)

0.417

2082

Left Ventricular End Systolic Volume (ml/m2)

− 0.62

− 3.73 (− 6.88, − 0.47)

0.025

− 0.04

− 0.27 (− 5.35, 5.08)

0.920

2082

Stroke Volume Index (ml/m2)

− 0.87

− 2.36 (− 4.37, − 0.31)

0.024

− 0.71

− 1.92 (− 5.07, 1.33)

0.243

2082

Cardiac Index (L/min/m2)

− 0.05

− 2.26 (− 4.53, 0.07)

0.058

0.12

5.10 (1.28, 9.07)

0.009

2082

Myocardial Contraction Fraction (%)

− 0.04

− 0.81 (− 2.98, 1.40)

0.469

− 1.64

− 2.96 (− 6.25, 0.45)

0.089

2082

Left Ventricular Mass Index (g/m2)

 < 0.01

0.01 (− 2.14, 2.21)

0.997

2.68

3.28 (− 0.19, 6.88)

0.064

2082

Relative Wall Thickness (cm)

0.01

1.54 (− 0.23, 3.35)

0.089

0.01

2.63 (− 0.16, 5.50)

0.065

2082

  1. Each row represents a separate model for Left ventricular outcomes and were adjusted for diabetes duration, Hypertension age, gender, physical activity, highest level of education, nutrition pattern, dyslipidemia smoking status, alcohol use, use of crack or cocaine, beta blocker, calcium channel blockers, diuretics, Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blocker. Only LVEF, LV FS, MCF and RWT which were additionally controlled for log of BMI